E Fund Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$55.5K	Buy	+18,070	New	+$78.3K	﹤0.01%	487
2025 Q2	$94.6K	Sell	10,259 -1,652	-14%	-$14.1K	﹤0.01%	377
2025 Q1	$102K	Buy	+11,911	New	+$112K	﹤0.01%	382
2024 Q3	–	Sell	-13,623	Closed	-$57.5K	–	355
2024 Q2	$57.5K	Sell	13,623 -18,036	-57%	-$73K	﹤0.01%	315
2024 Q1	$161K	Buy	31,659 +19,271	+156%	+$108K	0.01%	358
2023 Q4	$115K	Sell	12,388 -1,520	-11%	-$10.5K	0.01%	300
2023 Q3	$91K	Sell	13,908 -4,945	-26%	-$39.4K	0.01%	286
2023 Q2	$153K	Sell	18,853 -7,561	-29%	-$64.8K	0.01%	289
2023 Q1	$226K	Buy	26,414 +2,052	+8%	+$20.5K	0.02%	275
2022 Q4	$226K	Buy	24,362 +5,547	+29%	+$59.3K	0.02%	280
2022 Q3	$194K	Sell	18,815 -429	-2%	-$4.53K	0.02%	309
2022 Q2	$193K	Buy	19,244 +777	+4%	+$7.36K	0.02%	303
2022 Q1	$227K	Buy	+18,467	New	+$227K	0.01%	272